CONSULTA CRT-D/MAXIMO II CRT-D/CONCERTO II CRT-D
FDA premarket approval P010031/S133 · decided 2009-04-01
Approval details
- PMA number
- P010031
- Supplement
- S133
- Supplement type
- 135 Review Track For 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- CONSULTA CRT-D/MAXIMO II CRT-D/CONCERTO II CRT-D
- Applicant
- Medtronic Cardiac Rhythm Disease Management
- Date received
- 2008-11-17
- Decision date
- 2009-04-01
- Days to decision
- 135 days
- Decision code
- APPR
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Mounds View, MN
- Statement
- APPROVAL OF THE HYBRID FINAL FUNCTIONAL TESTING.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.